Laurence Robel

Laurence Robel

Auto-generated profile, based on publicly available information

Laurence Robel

Service de psychiatrie de l'enfant et de l'adolescent, hôpital Necker-Enfants-Malades, 149-162, rue de Sèvres, 75015 Paris, France; CESP, USPC, Inserm U1178, université Paris-Descartes, 94800 Villejuif, France; PCPP, université Paris-Descartes, Sorbonne Paris-Cité, 92100 Boulogne-Billancourt, France

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2008 in Pediatrics
Verified
Journal Article
Closed access
APAnne Philippe
Anne Philippe
NBNathalie Boddaert
Nathalie Boddaert
LVLaurence Vaivre-Douret
Laurence Vaivre-Douret
LRLaurence Robel
Laurence Robel
LDLaurent Danon-Boileau
Laurent Danon-Boileau
AMArnold Munnich
Arnold Munnich
OBJECTIVE. The 22q13.3 deletion syndrome (Online Mendelian Inheritance in Man No. 606232) is a neurodevelopmental disorder that includes hypotonia, severely impaired development of speech and language, autistic-like behavior, and minor dysmorphic features. Although the number of reported cases is increasing, the 22q13.3 deletion remains underdiagnosed because of failure in recognizing the clinical phenotype and detecting the 22qter deletion by routine chromosome analyses. Our goal is to contribute to the description of the neurobehavioral phenotype and brain abnormalities of this microdeletional syndrome. METHODS. We assessed neuromotor, sensory, language, communication, and social development and performed cerebral MRI and study of regional cerebral blood flow measured by positron emission tomography in 8 children carrying the 22q13.3 deletion. RESULTS. Despite variability in expression and severity, the children shared a common developmental profile characterized by hypotonia, sleep disorders, and poor response to their environment in early infancy; expressive language deficit contrasting with emergence of social reciprocity from ages ∼3 to 5 years; sensory processing dysfunction; and neuromotor disorders. Brain MRI findings were normal or showed a thin or morphologically atypical corpus callosum. Positron emission tomography study detected a localized dysfunction of the left temporal polar lobe and amygdala hypoperfusion. CONCLUSIONS. The developmental course of the 22q13.3 deletion syndrome belongs to pervasive developmental disorders but is distinct from autism. An improved description of the natural history of this syndrome should help in recognizing this largely underdiagnosed condition.

1 August 2004 in European Child & Adolescent Psychiatry
Verified
Journal Article
Closed access
PDF file
LRLaurence Robel
Laurence Robel
LVLaurence Vaivre-Douret
Laurence Vaivre-Douret
APAntoine Perier
Antoine Perier
MFMartine F. Flament
Martine F. Flament
KEKéreddin Ennouri
Kéreddin Ennouri
MMMarie-Christine Mouren-Siméoni
Marie-Christine Mouren-Siméoni

28 June 2015 in Journal of Autism and Developmental Disorders
Verified
Journal Article
Closed access
PDF file
ACArnaud Carré
Arnaud Carré
CCCoralie Chevallier
Coralie Chevallier
LRLaurence Robel
Laurence Robel
CBCaroline Barry
Caroline Barry
AMAnne-Solène Maria
Anne-Solène Maria
SBSylvie Berthoz
Sylvie Berthoz

21 October 2015 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
APAnne Philippe
Anne Philippe
YCYann Craus
Yann Craus
MRMarlène Rio
Marlène Rio
NBNadia Bahi-Buisson
Nadia Bahi-Buisson
NBNathalie Boddaert
Nathalie Boddaert
LRLaurence Robel
Laurence Robel
Deletions and mutations involving the SHANK3 gene lead to a nonspecific clinical presentation with moderate to profound intellectual disability, severely delayed or absent speech, and autism spectrum disorders (ASD). Better knowledge of the clinical spectrum of SHANK3 haploinsufficiency is useful to facilitate clinical care monitoring and to guide molecular diagnosis, essential for genetic counselling. Here, we report a detailed clinical description of a 10-year-old girl carrying a pathogenic interstitial 22q13.3 deletion encompassing only the first 17 exons of SHANK3. The clinical features displayed by the girl strongly suggested the diagnosis of dementia infantilis, described by Heller in 1908, also known as childhood disintegrative disorder. Our present case confirms several observations according to which regression may be part of the clinical phenotype of SHANK3 haploinsufficiency. Therefore, we think it is crucial to look for mutations in the gene SHANK3 in patients diagnosed for childhood disintegrative disorder or any developmental disorder with a regressive pattern involving social and communicative skills as well as cognitive and instinctual functions, with onset around 3 years.

1 December 2008 in Psychiatric Genetics
Verified
Journal Article
Closed access
FLFabrice Laroche
Fabrice Laroche
NRNicolas Ramoz
Nicolas Ramoz
SLSophie Leroy
Sophie Leroy
CFCélia Fortin
Célia Fortin
BRBérangère Rousselot-Paillet
Bérangère Rousselot-Paillet
LRLaurence Robel
Laurence Robel
Objectives Autism (MIM♯209850) and schizophrenia (MIM♯181500) are both neurodevelopmental psychiatric disorders characterized by a highly genetic component. Homeogenes and forkhead genes encode transcription factors, which have been involved in brain development and cell differentiation. Thus, they are relevant candidate genes for psychiatric disorders. Genetic studies have reported an association between autism and DLX2, HOXA1, EN2, ARX, and FOXP2 genes whereas only three studies of EN2, OTX2, and FOXP2 were performed on schizophrenia. Interestingly, most of these candidate genes contain trinucleotide repeats coding for polyamino acid stretch in which instability can be the cause of neurodevelopmental disorders. Our goal was to identify variations of coding trinucleotide repeats in schizophrenia, autism, and idiopathic mental retardation. Methods We screened the coding trinucleotide repeats of OTX1, EN1, DLX2, HOXA1, and FOXP2 genes in populations suffering from schizophrenia (247 patients), autism (98 patients), and idiopathic mental retardation (56 patients), and compared them with control populations (112 super controls and 202 healthy controls). Results Novel deletions and insertions of coding trinucleotide repeats were found in the DLX2, HOXA1, and FOXP2 genes. Most of these variations were detected in controls and no difference in their distribution was observed between patient and control groups. Two different polymorphisms in FOXP2 were, however, found only in autistic patients and the functional consequences of these variations of repeats have to be characterized and correlated to particular clinical features. Conclusion This study did not identify specific disease risk variants of trinucleotide repeats in OTX1, EN1, DLX2, HOXA1, and FOXP2 candidate genes in neurodevelopmental psychiatric disorders.

18 July 2013 in European Child & Adolescent Psychiatry
Verified
Journal Article
Closed access
PDF file
LRLaurence Robel
Laurence Robel
BRB. Rousselot-Pailley
B. Rousselot-Pailley
CFC. Fortin
C. Fortin
MLM. Levy-Rueff
M. Levy-Rueff
BGB. Golse
B. Golse
BFB. Falissard
B. Falissard